SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001585364-24-000017
Filing Date
2024-03-07
Accepted
2024-03-07 20:31:49
Documents
4
Period of Report
2024-03-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1709861497.html 4  
1 FORM 4 wk-form4_1709861497.xml 4 7505
2 EX-24 svendandersenpoa.htm EX-24 3617
3 GRAPHIC svendandersenpoa001.jpg GRAPHIC 209927
4 GRAPHIC svendandersenpoa002.jpg GRAPHIC 26495
  Complete submission text file 0001585364-24-000017.txt   338438
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Issuer) CIK: 0001585364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PERRIGO COMPANY PLC 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address
Andersen Svend (Reporting) CIK: 0001699722 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36353 | Film No.: 24732090